Trials / Completed
CompletedNCT00248690
ICP Versus Intracranial Compliance Guided Management in SAH
Intracranial Pressure (ICP) Versus Intracranial Compliance (ICC) Guided Management in Subarachnoid Hemorrhage; - a Prospective, Randomized Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether treatment guided also by ICP mean wave amplitude improves outcome compared to international standard care in patients with SAH.
Detailed description
In this study SAH-patients are randomized to treatment based on international standard care (ICP/CPP guided therapy) or intracranial compliance (ICP mean wave amplitude) guided therapy in addition to ICP/CPP guided therapy. Main outcome variables are survival and neurological outcome after 3 and 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ICP mean wave amplitude | Appropriate measures when ICP mean wave amplitude is to high, e.g. CSF drainage |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2009-02-01
- Completion
- 2009-06-01
- First posted
- 2005-11-04
- Last updated
- 2011-01-19
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00248690. Inclusion in this directory is not an endorsement.